BOI:EPA
Boiron
18,85 €
arrow_downward
-0,79%(-0,15) 1 d.
17. 11., 12:00:15 GMT+1 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre BOI…
Otvoriť
19,00 €
Vysoká
19,15 €
Nízka
18,85 €
Trh. kap.
330,73 mil.
Priem. obj.
4,67 tis.
Objem
379,00
Pomer cena/zárobky
12,50
Max. za 52 týž.
32,25 €
Min. za 52 týž.
16,90 €
Výnosy na akciu
1,51 €
Akcie v obehu
17,55 mil.
Počet zamestnancov
3 tis.
Otvoriť
19,00 €
Vysoká
19,15 €
Nízka
18,85 €
Trh. kap.
330,73 mil.
Priem. obj.
4,67 tis.
Objem
379,00
Pomer cena/zárobky
12,50
Max. za 52 týž.
32,25 €
Min. za 52 týž.
16,90 €
Výnosy na akciu
1,51 €
Akcie v obehu
17,55 mil.
Počet zamestnancov
3 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Investor's Business Daily
·
pred 14 minútami
Analysts Expect 4 S&P 500 Stocks To Outgrow Nvidia Next Year
Benzinga
·
pred 30 minútami
Shipping Stocks Rose 4.5% Last Week, Outperforming S&P 500; United Maritime Led Gains
Quartz
·
pred 24 minútami
The Dow fell more than 700 points on Monday and the S&P 500 lost 1.9%
The Motley Fool
·
pred 1 hodinou
Will Your S&P 500 Index Fund Be Forced to Buy Anthropic? Here’s What the Rules Say.
Profil
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
Informácie o subjekte Boiron
Generálny riaditeľ-
Zamestnanci2,62 tis.
Dátum založenia7. 6. 1932
Hlavné sídlo-
OdvetvieHealth Care
Odvetvie-
Webboiron.fr